5-(α,α,α-Trifluoro-m-tolyloxymethyl)-2-oxazolidinethione, referred to as U-11634 (Youngdale, Duncan, Emmert & Lednicer, 1966), inhibits pregnancy in rats when administered at doses of 2·5 mg or above for the first 7 days of pregnancy or at a single dose of 5·0 mg or above when administered on the 4th day of pregnancy. In classical hormone assays, U-11634 was devoid of uterotrophic, anti-oestrogenic (in immature ovariectomized rats), progestational (McPhail assay), androgenic (in immature castrate rats), and gonadotrophininhibiting (in immature intact male rats) activities at therapeutic doses or reasonable multiples thereof (Duncan, Johnston & Lyster, 1965). It did not inhibit endometrial proliferation (McPhail assay, three rabbits/dose) when administered subcutaneously at doses of 0·0, 2·5, 25 and 50 mg/kg concomitant with 0·20 mg of progesterone injected at a separate site.
To assess further the effect of U-11634 on the pituitary-gondal axis,
Reproduction is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 98 | 15 | 1 |
PDF Downloads | 66 | 19 | 3 |